Back

9 July 2025

The ITA reports that taekwondo athlete Ulugbek Rashitov accepted a 2-year sanction for three whereabouts failures

The International Testing Agency (ITA), on behalf of World Taekwondo (WT), reports that Uzbek taekwondo athlete Ulugbek Rashitov has accepted a two-year period of ineligibility for an Anti-Doping Rule Violation (ADRV).

¹ Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 of the WT anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed a WT/ITA decision.

² Athletes included in a Registered Testing Pool (RTP), such as Ulugbek Rashitov, have the obligation to provide daily whereabouts as well as a specific daily 60-minute time slot where they will be available for testing. The purpose is to allow anti-doping organisations to locate athletes for unannounced out-of-competition testing. Any combination of three missed tests (which relate to the athletes’ unavailability with respect to their 60-minute time slot) and/or filing failures (which are caused by the athletes’ failure to provide accurate whereabouts) committed within a twelve-month period amount to an ADRV as per article 2.4 of the WT ADR and World Anti-Doping Code. The consequences for such ADRV are a period of Ineligibility between one and two years and the disqualification of results obtained since the date of the ADRV, namely the date of the occurrence of third whereabouts failure (article 10.3.2 WT ADR).

Share

Cookie Policy & Privacy Notice

We use cookies on our website to personalize content, to analyze traffic on our website to provide social media features. We share your data with our analytics partners and social media content providers. Find out more

The privacy policy can be accessed here

Your current state: Consent rejected.


Accept Reject Read More